Vancomycin (as HCl) 500mg/vial, 1g/vial; lyophilized pwd for IV infusion after reconstitution and dilution. Not for prophylaxis of endophthalmitis. Renal insufficiency. Monitor hearing, blood, renal ...
Guidelines recommend against use of midline catheters for vancomycin-based outpatient parenteral antimicrobial therapy (OPAT), but evidence supporting the guidance is limited. This retrospective study ...
Ready-to-infuse sepsis therapy marks new advancement in time-critical treatment LONDON, July 2, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today ...
In late 2021, the Rome Proposal for diagnosing acute exacerbations of chronic obstructive pulmonary disease (AECOPD) and grading their severity was published. The 2023 Global Strategy for the ...
Vancomycin is a common antibiotic used to treat gram-positive bacterial infections. It targets a key building block of the bacterial cell wall called Lipid II, but it can’t reach this lipid in ...
Four medicines received positive opinions from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) last week, expanding treatment options for cancer, rare ...
Experts caution against premature discontinuation, emphasising adherence to prescribed doses. With rising antibiotic resistance, India's drug practices are under scrutiny. Understand the ongoing ...
NEW YORK (Reuters Health) - While some studies have suggested that giving babies antibiotics might boost their risk of asthma later on, a new analysis concludes that much of that evidence is flawed.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results